Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China.
Yuequan ShiJian FangCheng-Zhi ZhouAnwen LiuYan WangQingwei MengCuimin DingBin AiYangchun GuYu YaoHong SunHui GuoCuiying ZhangXia SongJunling LiBei XuZhiqiang HanMeijun SongTingyu TangPeifeng ChenHongmin LuYongjie ShuiGuangyuan LouDongming ZhangJia LiuXiaoyan LiuXiangning LiuXiaoxing GaoQing ZhouMin-Jiang ChenJing ZhaoWei ZhongYan XuMengzhao WangPublished in: Thoracic cancer (2021)
The incidence rate of irAEs was 26.9% in a real-world setting. IrAEs might be related to a better DCR, but clinicians should be more aware of irAE recognition and management in clinical practice.